资讯

STAT56 分钟
Pharmalittle: We’re reading about FDA probing deaths after Sarepta treatment, a Regeneron ...
The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...